微創醫療(00853.HK)預期中期銷售收入同比實現雙位數增長
格隆匯7月30日丨微創醫療(00853.HK)公吿,截至2021年6月30日止6個月,集團錄得歸屬於公司權益股東的期間虧損約9000萬美元至1億美元(去年同期錄得歸屬於公司權益股東的期間虧損約6560萬美元)。
該變動主要歸因於(i)冠脈支架全國集中帶量採購政策帶來的降價影響;(ii)研發投入的同比顯著增加;(iii)可轉債發行的一次性交易費用。
同時,報吿期內集團的銷售收入同比實現雙位數增長,部分抵銷上述不利影響。該增長主要歸因於全國集中帶量採購政策帶來冠脈支架銷量的大幅增長、快速市場推廣、新產品收入貢獻以及新型冠狀病毒疫情恢復帶來的擇期手術量回升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.